Floatz logo

373 assets in Non-Hodgkin Lymphoma

Therapeutic assets addressing Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Sirpant-M
Non-Hodgkin Lymphoma
SIRPant Immunotherapeutics, Inc.P1CC (43)
Stk-009
Non-Hodgkin Lymphoma
SynthekineP1CC (43)
Syncar-001
Non-Hodgkin Lymphoma
SynthekineP1CC (43)
Synkir-310
Non-Hodgkin Lymphoma
Verismo TherapeuticsP1CC (43)
Taa-Specific Ctls
Non-Hodgkin Lymphoma
Baylor College of MedicineP1CC (43)
Teclistamab
Non-Hodgkin Lymphoma
CellCentric Ltd.P1/2CC (43)
Tln-121
Non-Hodgkin Lymphoma
Treeline Biosciences, Inc.P1CC (43)
Tln-254
Non-Hodgkin Lymphoma
Treeline Biosciences, Inc.P1CC (43)
tr115
Non-Hodgkin Lymphoma
Tarapeutics Science Inc.P1CC (43)
Ub-Vv111
Non-Hodgkin Lymphoma
Umoja BiopharmaP1CC (43)
Valemetostat
Non-Hodgkin Lymphoma
CelgeneP1/2CC (43)
Vancomycin
Non-Hodgkin Lymphoma
Abramson Cancer Center at Penn MedicineP1CC (43)
yh004
Non-Hodgkin Lymphoma
Eucure (Beijing) Biopharma Co., LtdP1CC (43)
ace1831
Non-Hodgkin Lymphoma
Acepodia Biotech, Inc.P1CC (42)
Bms-986345
Non-Hodgkin Lymphoma
H. Lee Moffitt Cancer Center and Research InstituteP1CC (42)
Bpx-501 T Cells
Non-Hodgkin Lymphoma
Bellicum PharmaceuticalsP1/2CC (42)
cd19-ucart
Non-Hodgkin Lymphoma
Bioray LaboratoriesP1CC (42)
Immunoglobulin G4, Anti-(Human Cd3 Antigen) (Recombinant Human Monoclonal Jnj-75348780 ?4-Chain), Disulfide With Recombinant Human Monoclonal Jnj-75348780 ? Chain, (229?126?),(232?129?)-Bis(Disulfide) With Immunoglobulin, Anti-(Human Sialic Acid-Binding Ig-Like Lectin 2) (Recombinant Human Single-Domain Vhh Fragment)
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1CC (42)
Jnj-64619178
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1CC (42)
kt-413
Non-Hodgkin Lymphoma
Kymera Therapeutics, Inc.P1CC (42)
Loncastuximab Tesirine
Non-Hodgkin Lymphoma
Paolo Caimi, MDP1CC (42)
lp-118
Non-Hodgkin Lymphoma
Newave Pharmaceutical IncP1CC (42)
Zn-D5
Non-Hodgkin Lymphoma
Zentera Therapeutics HK LimitedP1CC (42)
64cu-grip b
Non-Hodgkin Lymphoma
Michael RandallP1CC (41)
Dextromethorphan
Non-Hodgkin Lymphoma
Murdoch Childrens Research InstituteP1CC (41)
lv20.19 car t cells
Non-Hodgkin Lymphoma
Medical College of WisconsinP1CC (41)
mc-1-50
Non-Hodgkin Lymphoma
Chongqing Precision Biotech Co., LtdP1CC (41)
Tmcd19-Il18
Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (41)
28137 T cells
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
3d189
Non-Hodgkin Lymphoma
3D MedicinesP1C (39)
Abbv-291
Non-Hodgkin Lymphoma
AbbVieP1C (39)
Abbv-525
Non-Hodgkin Lymphoma
AbbVieP1C (39)
Adi-001
Non-Hodgkin Lymphoma
Adicet TherapeuticsP1C (39)
Allodepleted T Cells
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Allogeneic Natural Killer Cells
Non-Hodgkin Lymphoma
Paolo Caimi, MDP1C (39)
Apg-5918
Non-Hodgkin Lymphoma
Ascentage Pharma Group Inc.P1C (39)
aur103
Non-Hodgkin Lymphoma
Aurigene Discovery Technologies LimitedP1C (39)
aur105
Non-Hodgkin Lymphoma
Aurigene Discovery Technologies LimitedP1C (39)
Autologous Car.Cd30 Ebv Specific-Ctls
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Axt-1003
Non-Hodgkin Lymphoma
Axter Therapeutics (Beijing) Co., LtdP1C (39)
Azer-Cel
Non-Hodgkin Lymphoma
Imugene LimitedP1C (39)
Bcma Targeted Car T-Cells
Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (39)
Btx-1188
Non-Hodgkin Lymphoma
Biotheryx, Inc.P1C (39)
c7r.cd30.car-ebvst cells
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
Car-Nk-Cd19 Cells
Non-Hodgkin Lymphoma
Beijing Boren HospitalP1C (39)
cc312
Non-Hodgkin Lymphoma
CytoCares IncP1C (39)
cc-96673
Non-Hodgkin Lymphoma
CelgeneP1C (39)
CD19.CAR-multiVSTs
Non-Hodgkin Lymphoma
Baylor College of MedicineP1C (39)
cd19 specific chimeric antigen receptor t cell
Non-Hodgkin Lymphoma
Nationwide Children's HospitalEarly P1C (39)
cd38-sada:177lu-dota complex
Non-Hodgkin Lymphoma
Y-mAbs TherapeuticsP1C (39)
Showing 251 to 300 of 373 assets
PreviousPage 6 of 8Next